Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach
Autor(a) principal: | |
---|---|
Data de Publicação: | 2024 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Brazilian Journal of Implantology and Health Sciences |
Texto Completo: | https://bjihs.emnuvens.com.br/bjihs/article/view/1652 |
Resumo: | In this study, various therapeutic strategies are examined for the treatment of Tourette Syndrome, with an emphasis on pharmacological and non-pharmacological approaches. Initially, we highlight the effectiveness of recent pharmacological interventions developed, emphasizing their ability to control symptoms of the disease and improve patients' quality of life. These emerging therapies are not limited to symptom relief but also aim to address the underlying causes of the condition, considering the complex interaction between neurobiological and environmental factors. In addition to pharmacological interventions, innovative non-pharmacological approaches are being explored, such as behavioral therapies and lifestyle modulation. These strategies include cognitive-behavioral therapies, social skills training, and relaxation techniques, which have been shown to be effective in reducing tics and managing stress. Ongoing research in this field is crucial to identify the most effective approaches and adapt them to individual patient needs. Furthermore, it is important to highlight the role of specific medications in the treatment of Tourette Syndrome, including antipsychotics, dopaminergic agonists, and adjuvant agents. These medications aim to control motor and vocal tics as well as the behavioral symptoms associated with the condition, providing relief to patients affected by the Syndrome. In summary, the approach to treatment is increasingly focused on the combination of pharmacological and non-pharmacological therapy. The integration of these therapeutic strategies can offer a more comprehensive and personalized approach to managing the condition, significantly improving the quality of life of patients. However, further research is needed to fully understand the underlying mechanisms and optimize the use of these therapeutic interventions in clinical practice. |
id |
GOE-1_982cbff100488ff30655795f7e4c44ac |
---|---|
oai_identifier_str |
oai:ojs.bjihs.emnuvens.com.br:article/1652 |
network_acronym_str |
GOE-1 |
network_name_str |
Brazilian Journal of Implantology and Health Sciences |
repository_id_str |
|
spelling |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological ApproachEstratégias Terapêuticas na Síndrome de Tourette: Abordagem Farmacológica e não FarmacológicaSíndrome de Tourette; Estratégias Terapêuticas; Abordagem Farmacológica/não Farmacológica.Tourette Syndrome; Therapeutic Strategies; Pharmacological/non-pharmacological Approach. In this study, various therapeutic strategies are examined for the treatment of Tourette Syndrome, with an emphasis on pharmacological and non-pharmacological approaches. Initially, we highlight the effectiveness of recent pharmacological interventions developed, emphasizing their ability to control symptoms of the disease and improve patients' quality of life. These emerging therapies are not limited to symptom relief but also aim to address the underlying causes of the condition, considering the complex interaction between neurobiological and environmental factors. In addition to pharmacological interventions, innovative non-pharmacological approaches are being explored, such as behavioral therapies and lifestyle modulation. These strategies include cognitive-behavioral therapies, social skills training, and relaxation techniques, which have been shown to be effective in reducing tics and managing stress. Ongoing research in this field is crucial to identify the most effective approaches and adapt them to individual patient needs. Furthermore, it is important to highlight the role of specific medications in the treatment of Tourette Syndrome, including antipsychotics, dopaminergic agonists, and adjuvant agents. These medications aim to control motor and vocal tics as well as the behavioral symptoms associated with the condition, providing relief to patients affected by the Syndrome. In summary, the approach to treatment is increasingly focused on the combination of pharmacological and non-pharmacological therapy. The integration of these therapeutic strategies can offer a more comprehensive and personalized approach to managing the condition, significantly improving the quality of life of patients. However, further research is needed to fully understand the underlying mechanisms and optimize the use of these therapeutic interventions in clinical practice. Neste estudo, várias estratégias terapêuticas são examinadas para o tratamento da Síndrome de Tourette, com ênfase na abordagem farmacológica e não farmacológica. Inicialmente, destacamos a eficácia das recentes intervenções farmacológicas desenvolvidas, enfatizando sua capacidade de controlar os sintomas da doença e melhorar a qualidade de vida dos pacientes. Essas terapias emergentes não se limitam apenas ao alívio dos sintomas, mas também buscam abordar as causas subjacentes da condição, considerando a complexa interação entre fatores neurobiológicos e ambientais. Além das intervenções farmacológicas, estão sendo exploradas abordagens não farmacológicas inovadoras, como terapias comportamentais e modulação do estilo de vida. Essas estratégias incluem terapias cognitivo-comportamentais, treinamento de habilidades sociais e técnicas de relaxamento, que demonstraram ser eficazes na redução dos tiques e no gerenciamento do estresse. A pesquisa contínua nesse campo é crucial para identificar as abordagens mais eficazes e adaptá-las às necessidades individuais dos pacientes. Além disso, é importante destacar o papel dos medicamentos específicos no tratamento da Síndrome de Tourette, incluindo antipsicóticos, agonistas dopaminérgicos e agentes adjuvantes. Esses medicamentos visam controlar os tiques motores e vocais, bem como os sintomas comportamentais associados à condição, proporcionando alívio aos pacientes afetados pela Síndrome. Em resumo, a abordagem no tratamento está cada vez mais focada na combinação da terapia farmacológica e não farmacológica. A integração dessas estratégias terapêuticas pode oferecer uma abordagem mais abrangente e personalizada para o manejo da condição, melhorando significativamente a qualidade de vida dos pacientes. No entanto, são necessárias mais pesquisas para entender completamente os mecanismos subjacentes e otimizar o uso dessas intervenções terapêuticas na prática clínica.Specialized Dentistry Group2024-03-12info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://bjihs.emnuvens.com.br/bjihs/article/view/165210.36557/2674-8169.2024v6n3p997-1010Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 3 (2024): BJIHS QUALIS B3; 997-1010Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 3 (2024): BJIHS QUALIS B3; 997-1010Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 3 (2024): BJIHS QUALIS B3; 997-10102674-8169reponame:Brazilian Journal of Implantology and Health Sciencesinstname:Grupo de Odontologia Especializada (GOE)instacron:GOEporhttps://bjihs.emnuvens.com.br/bjihs/article/view/1652/1844Copyright (c) 2024 Ana Laura Zanett Alvarenga, Caio Aloísio de Oliveira Cardoso , Caio Cesar Queiroz Nogueira, Arthur Henrique dos Santos Vieira, Stefânia Ungaro Lanfredihttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessZanett Alvarenga, Ana Laura Aloísio de Oliveira Cardoso , CaioQueiroz Nogueira, Caio Cesardos Santos Vieira, Arthur HenriqueUngaro Lanfredi, Stefânia2024-03-12T19:41:44Zoai:ojs.bjihs.emnuvens.com.br:article/1652Revistahttps://bjihs.emnuvens.com.br/bjihsONGhttps://bjihs.emnuvens.com.br/bjihs/oaijournal.bjihs@periodicosbrasil.com.br2674-81692674-8169opendoar:2024-03-12T19:41:44Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE)false |
dc.title.none.fl_str_mv |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach Estratégias Terapêuticas na Síndrome de Tourette: Abordagem Farmacológica e não Farmacológica |
title |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach |
spellingShingle |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach Zanett Alvarenga, Ana Laura Síndrome de Tourette; Estratégias Terapêuticas; Abordagem Farmacológica/não Farmacológica. Tourette Syndrome; Therapeutic Strategies; Pharmacological/non-pharmacological Approach. |
title_short |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach |
title_full |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach |
title_fullStr |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach |
title_full_unstemmed |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach |
title_sort |
Therapeutic Strategies in Tourette Syndrome: Pharmacological and Non-pharmacological Approach |
author |
Zanett Alvarenga, Ana Laura |
author_facet |
Zanett Alvarenga, Ana Laura Aloísio de Oliveira Cardoso , Caio Queiroz Nogueira, Caio Cesar dos Santos Vieira, Arthur Henrique Ungaro Lanfredi, Stefânia |
author_role |
author |
author2 |
Aloísio de Oliveira Cardoso , Caio Queiroz Nogueira, Caio Cesar dos Santos Vieira, Arthur Henrique Ungaro Lanfredi, Stefânia |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Zanett Alvarenga, Ana Laura Aloísio de Oliveira Cardoso , Caio Queiroz Nogueira, Caio Cesar dos Santos Vieira, Arthur Henrique Ungaro Lanfredi, Stefânia |
dc.subject.por.fl_str_mv |
Síndrome de Tourette; Estratégias Terapêuticas; Abordagem Farmacológica/não Farmacológica. Tourette Syndrome; Therapeutic Strategies; Pharmacological/non-pharmacological Approach. |
topic |
Síndrome de Tourette; Estratégias Terapêuticas; Abordagem Farmacológica/não Farmacológica. Tourette Syndrome; Therapeutic Strategies; Pharmacological/non-pharmacological Approach. |
description |
In this study, various therapeutic strategies are examined for the treatment of Tourette Syndrome, with an emphasis on pharmacological and non-pharmacological approaches. Initially, we highlight the effectiveness of recent pharmacological interventions developed, emphasizing their ability to control symptoms of the disease and improve patients' quality of life. These emerging therapies are not limited to symptom relief but also aim to address the underlying causes of the condition, considering the complex interaction between neurobiological and environmental factors. In addition to pharmacological interventions, innovative non-pharmacological approaches are being explored, such as behavioral therapies and lifestyle modulation. These strategies include cognitive-behavioral therapies, social skills training, and relaxation techniques, which have been shown to be effective in reducing tics and managing stress. Ongoing research in this field is crucial to identify the most effective approaches and adapt them to individual patient needs. Furthermore, it is important to highlight the role of specific medications in the treatment of Tourette Syndrome, including antipsychotics, dopaminergic agonists, and adjuvant agents. These medications aim to control motor and vocal tics as well as the behavioral symptoms associated with the condition, providing relief to patients affected by the Syndrome. In summary, the approach to treatment is increasingly focused on the combination of pharmacological and non-pharmacological therapy. The integration of these therapeutic strategies can offer a more comprehensive and personalized approach to managing the condition, significantly improving the quality of life of patients. However, further research is needed to fully understand the underlying mechanisms and optimize the use of these therapeutic interventions in clinical practice. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03-12 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1652 10.36557/2674-8169.2024v6n3p997-1010 |
url |
https://bjihs.emnuvens.com.br/bjihs/article/view/1652 |
identifier_str_mv |
10.36557/2674-8169.2024v6n3p997-1010 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://bjihs.emnuvens.com.br/bjihs/article/view/1652/1844 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Specialized Dentistry Group |
publisher.none.fl_str_mv |
Specialized Dentistry Group |
dc.source.none.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences ; Vol. 6 No. 3 (2024): BJIHS QUALIS B3; 997-1010 Brazilian Journal of Implantology and Health Sciences ; Vol. 6 Núm. 3 (2024): BJIHS QUALIS B3; 997-1010 Brazilian Journal of Implantology and Health Sciences ; v. 6 n. 3 (2024): BJIHS QUALIS B3; 997-1010 2674-8169 reponame:Brazilian Journal of Implantology and Health Sciences instname:Grupo de Odontologia Especializada (GOE) instacron:GOE |
instname_str |
Grupo de Odontologia Especializada (GOE) |
instacron_str |
GOE |
institution |
GOE |
reponame_str |
Brazilian Journal of Implantology and Health Sciences |
collection |
Brazilian Journal of Implantology and Health Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Implantology and Health Sciences - Grupo de Odontologia Especializada (GOE) |
repository.mail.fl_str_mv |
journal.bjihs@periodicosbrasil.com.br |
_version_ |
1796798445825032192 |